West syndrome, can topiramate be on top?

Raidah S Al-Baradie1, Maha A Elseed

  • 1Neuroscience Center, King Fahd Specialist Hospital, PO Box 15215, Dammam 314444, Kingdom of Saudi Arabia. raidah_albaradie@hotmail.com

Insights

Topiramate effectively reduced infantile spasms and ancillary seizures in young patients, showing clinical improvement but not significant EEG changes. The treatment was generally well-tolerated with few side effects.

Area of Science:

  • Pediatric Neurology
  • Clinical Pharmacology
  • Epileptology

Background:

  • Infantile spasms, a severe epilepsy syndrome, require prompt and effective treatment.
  • West syndrome is characterized by infantile spasms, hypsarrhythmia on EEG, and developmental delay.
  • Identifying effective antiepileptic drugs for infantile spasms is crucial for improving patient outcomes.

Purpose of the Study:

  • To evaluate the efficacy of Topiramate in treating infantile spasms and associated ancillary seizures.
  • To assess the impact of Topiramate on electroencephalogram (EEG) findings in patients with infantile spasms.
  • To determine the tolerability and side effect profile of Topiramate in this pediatric population.

Main Methods:

  • A retrospective study involving 18 patients diagnosed with infantile spasms.
  • Patients were treated with Topiramate, with a maximum dosage of 12 mg/kg/day.
  • Data on seizure control, EEG changes, and adverse events were collected and analyzed.

Main Results:

  • Topiramate led to spasm freedom in 33% of patients and a ≥50% reduction in spasms in 44%.
  • For ancillary seizures, 25% of patients became seizure-free, and 25% experienced a ≥50% reduction.
  • While clinical seizure control was observed, EEG improvements were limited, with persistent hypsarrhythmia in 44% of cases. Minimal side effects were reported.

Conclusions:

  • Topiramate demonstrates significant efficacy in managing the clinical manifestations of West syndrome.
  • The drug's effect on EEG abnormalities in infantile spasms appears limited.
  • Topiramate is a well-tolerated treatment option for infantile spasms with a favorable side effect profile.
Abstract

Related Concept Videos

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...